Hanna Sartor

15PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutritional epidemiologyCancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 18, 2026
FDG-PET/CT-based treatment response predicts recurrence and overall survival in locally advanced cervical cancer.

|Feb 18, 2026
Breast cancer and liver metastases: an imaging perspective on the potential of resectability.

Erik Baubeta, Hanna Valind, Oskar Hagberg

|Jul 11, 2024
Mammographic features differ with body composition in women with breast cancer.

Hanna Sartor, Li Sturesdotter, Anna-Maria Larsson

|May 02, 2023
Radiologically enlarged cardiophrenic lymph nodes and CA-125 in relation to diaphragmatic carcinomatosis, surgical outcome, and overall survival in advanced ovarian cancer.

Alba Plana, Robert Talo, Nils-Olof Wallengren

|Feb 23, 2023
Metabolic parameters of [18F]FDG PET-CT before and after radiotherapy may predict survival and recurrence in cervical cancer.

Maria Markus, Hanna Sartor, Maria Bjurberg

|Apr 19, 2022
Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Nathalie Kliemann, Romain Ould Ammar, Carine Biessy

Pageof 3

Frequent Collaborators

4 joint publications

Sophia Zackrisson

3 joint publications

Elisabete Weiderpass

2 joint publications

Renée T Fortner

2 joint publications

Anne Tjønneland